Anaconda BioMed

Anaconda BioMed

Verified
Developing the next generation of catheters to perform safely and efficiently mechanical thrombectomies.

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2017201820192020202120222023
Revenues0000000000000000000000000000
% growth--155 %(57 %)125 %(7 %)35 %
EBITDA0000000000000000000000000000
% EBITDA margin-(3961 %)(1665 %)(3018 %)(1794 %)(1927 %)-
Profit0000000000000000000000000000
% profit margin-(5128 %)(2895 %)(9051 %)(4994 %)(7568 %)-
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

$0.0

round
investor

$0.0

round
investor investor investor investor

$0.0

round
N/A

$0.0

round
investor

$0.0

round
investor investor investor investor investor

$0.0

round

€10.0m

Debt
Total Funding000k

Recent News about Anaconda BioMed

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo